Suppr超能文献

相似文献

2
The burden of hospitalisations for community-acquired pneumonia (CAP) and pneumococcal pneumonia in adults in Spain (2003-2007).
Vaccine. 2011 Jan 10;29(3):412-6. doi: 10.1016/j.vaccine.2010.11.025. Epub 2010 Nov 25.
4
Decrease in the incidence and in hospital mortality of community-acquired pneumonia among children in Spain (2001-2014).
Vaccine. 2017 Jun 27;35(30):3733-3740. doi: 10.1016/j.vaccine.2017.05.055. Epub 2017 May 27.
5
Burden of pneumococcal community-acquired pneumonia in adults across Europe: A literature review.
Respir Med. 2018 Apr;137:6-13. doi: 10.1016/j.rmed.2018.02.007. Epub 2018 Feb 19.
6
Serotype prevalence in adults hospitalised with pneumococcal non-invasive community-acquired pneumonia.
Thorax. 2012 Jun;67(6):540-5. doi: 10.1136/thoraxjnl-2011-201092. Epub 2012 Feb 28.
8
Exploratory efficacy endpoints in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA).
Vaccine. 2017 Mar 1;35(9):1266-1272. doi: 10.1016/j.vaccine.2017.01.032. Epub 2017 Feb 4.

引用本文的文献

1
Abnormal serum phosphorus was associated with the outcome of community-acquired pneumonia.
Front Nutr. 2025 Jun 4;12:1435805. doi: 10.3389/fnut.2025.1435805. eCollection 2025.
2
Mapping and quantifying travel time to define health facility catchment areas in Blantyre city in Malawi.
Commun Med (Lond). 2025 Jun 11;5(1):227. doi: 10.1038/s43856-025-00845-3.
8
Pneumococcal vaccine uptake and vaccine effectiveness in older adults with invasive pneumococcal disease in Germany: A retrospective cohort study.
Lancet Reg Health Eur. 2021 Jun 3;7:100126. doi: 10.1016/j.lanepe.2021.100126. eCollection 2021 Aug.

本文引用的文献

2
Invasive pneumococcal disease caused by ceftriaxone-resistant Streptococcus pneumoniae in Taiwan.
J Microbiol Immunol Infect. 2018 Aug;51(4):500-509. doi: 10.1016/j.jmii.2016.12.004. Epub 2017 Jun 26.
3
Cost-effectiveness of pneumococcal vaccination strategies for the elderly in Korea.
PLoS One. 2017 May 12;12(5):e0177342. doi: 10.1371/journal.pone.0177342. eCollection 2017.
5
Incremental Cost-Effectiveness of 13-valent Pneumococcal Conjugate Vaccine for Adults Age 50 Years and Older in the United States.
J Gen Intern Med. 2016 Aug;31(8):901-8. doi: 10.1007/s11606-016-3651-0. Epub 2016 Mar 14.
6
Cost-Effectiveness of Vaccinating Immunocompetent ≥65 Year Olds with the 13-Valent Pneumococcal Conjugate Vaccine in England.
PLoS One. 2016 Feb 25;11(2):e0149540. doi: 10.1371/journal.pone.0149540. eCollection 2016.
9
Clinical usefulness of pneumococcal urinary antigen test, stratified by disease severity and serotypes.
J Infect Chemother. 2015 Sep;21(9):672-9. doi: 10.1016/j.jiac.2015.06.003. Epub 2015 Jun 19.
10
Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults.
N Engl J Med. 2015 Jul 30;373(5):415-27. doi: 10.1056/NEJMoa1500245. Epub 2015 Jul 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验